- Home
- RVPH vs CING Comparison
RVPH vs CING Comparison
Compare RVPH & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- CING
- Stock Information
- Founded
- RVPH 2006
- CING 2012
- Country
- RVPH United States
- CING United States
- Employees
- RVPH N/A
- CING N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- RVPH Health Care
- CING Health Care
- Exchange
- RVPH Nasdaq
- CING Nasdaq
- Market Cap
- RVPH 18.1M
- CING 21.6M
- IPO Year
- RVPH N/A
- CING 2021
- Fundamental
- Price
- RVPH $0.54
- CING $3.38
- Analyst Decision
- RVPH Strong Buy
- CING Strong Buy
- Analyst Count
- RVPH 6
- CING 4
- Target Price
- RVPH $3.33
- CING $33.00
- AVG Volume (30 Days)
- RVPH 7.9M
- CING 199.3K
- Earning Date
- RVPH 11-13-2025
- CING 11-07-2025
- Dividend Yield
- RVPH N/A
- CING N/A
- EPS Growth
- RVPH N/A
- CING N/A
- EPS
- RVPH N/A
- CING N/A
- Revenue
- RVPH N/A
- CING N/A
- Revenue This Year
- RVPH N/A
- CING N/A
- Revenue Next Year
- RVPH N/A
- CING N/A
- P/E Ratio
- RVPH N/A
- CING N/A
- Revenue Growth
- RVPH N/A
- CING N/A
- 52 Week Low
- RVPH $0.25
- CING $3.22
- 52 Week High
- RVPH $4.28
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- RVPH 48.43
- CING 37.55
- Support Level
- RVPH $0.45
- CING $3.57
- Resistance Level
- RVPH $0.59
- CING $3.81
- Average True Range (ATR)
- RVPH 0.06
- CING 0.21
- MACD
- RVPH -0.01
- CING -0.01
- Stochastic Oscillator
- RVPH 41.93
- CING 15.71
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.